BIO 2026: Building Supply Ahead of Demand

Ahead of BIO 2026, FUJIFILM Biotechnologies’ Toshi Iida outlines why the industry must pivot toward harmonized, modular facility networks to eliminate manufacturing bottlenecks and secure the global medicine supply. Music from #Uppbeat (free for Creators!): https://uppbeat.io/t/richard-smithson... License code: 6VTV63EGHQK9EBVH